IHS Chemical Week

EnviroTech :: Biotech

Lonza Secures Stem Cell Drug Supply Deal, Will Build Plant at Walkersville, MD

3:55 AM MDT | July 1, 2008 |

Alex Scott

Contract fine chemicals firm Lonza (Basel, Switzerland) says it has secured a deal with biotech firm Osiris Therapeutics (Columbia, MD) to manufacture what could be the world’s first stem cell drug. Lonza will build a new manufacturing facility at its Walkersville, MD site to manufacture the drug, the company says. Lonza has stated that the new manufacturing facility will cost millions of dollars to set up. Terms between the two companies were not disclosed.   Under the terms of the agreement Lonza will manufacture Osiris’s Prochymal stem cell...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa